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A case of co-infection with Plasmodium vivax and Mansonella ozzardi was detected in a blood sample from a person
who had shown symptoms of malaria and lived in a city that was close to the Argentina/Bolivia border. The case was
detected during a random revision of thick and thin smears from patients diagnosed with malaria from various towns
and cities located in north-western Argentina between 1983 and 2001. Trophozoites of P. vivax were observed in the
thin blood smear along with M. ozzardi microfilaria (larval form), which presented a long, slender, pointed anucleate tail
and the absence of the sheath. This last characteristic is shared with Mansonella perstans, Mansonella streptocerca and
Onchocerca volvulus. More rigorously controlled studies to detect other co-infection cases in the area as well as the
possibility of importation from Bolivia into Argentina are currently ongoing. The relationship between the malaria
parasite and microfilaria, the potential effect of malaria treatment on the development of M. ozzardi, and the possible
impact of this microfilaria on the immunity of a person against P. vivax are all still unknown. This contribution
constitutes a point of focus for future studies involving the interaction between the parasites and the potential risk that
humans are exposed to.Background
Malaria caused by Plasmodium vivax spans the greatest
geographic range [1]. Worldwide infections of P. vivax
are estimated between 130 and 390 million, with 2.6 bil-
lion individuals living at risk of infection [1,2]. Severe and
complicated malaria is generally caused by Plasmodium
falciparum; however, an increasing number of P. vivax
cases with severe manifestations have been reported re-
cently [1,3]. It should also be noted that some researchers
have cited cases of persons with malaria who do not
present the typical symptoms caused by infection with
P. vivax becoming asymptomatic patients [4-10].
The first cites of malarial disease in Argentina occurred
between the end of the 19th Century and the beginning of
the 20th Century and included reports on the geography
of the disease within the country [11], the presence of
both gametocytic and zygotic forms of Plasmodium* Correspondence: juliadantur@yahoo.com.ar
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distribution, and reproduction in any mediumparasites in Anopheles mosquitoes [12], and the parasito-
logical, epidemiological and entomological conditions of
malaria in north-western Argentina, recognizing the pres-
ence of “tropic malaria” (produced by P. falciparum), a
“tertian malaria” (produced by P. vivax) and a “quartan
malaria” (produced by Plasmodium malariae), with all
types co-existing at the same time [13].
Plasmodium vivax was the only malaria parasite
reported in the north-west region of the country since
the 1970s [14-19]. Positive testing of blood samples for
P. vivax was due to active searches for sick people
conducted by technicians of the Ministry of Health of
Argentina.
Anopheles pseudopunctipennis is the main malaria vec-
tor in north-western Argentina [14-16]. Malaria caused
by P. vivax and transmitted by A. pseudopunctipennis is
much more benign compared to infections caused by
other malarial parasites; commonly observed manifesta-
tions include intermediate episodes of fever and chills.
Nematodes that cause filariasis have been reported
throughout the tropical regions of the world [20-22].
Generally, they are found accidentally when patients
with symptoms of malaria visit the physician and thicktral Ltd. This is an Open Access article distributed under the terms of the
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parasites with the larval forms of the nematodes called
microfilaria. The presence of microfilaria infection in
Argentina was recognized by malaria surveys in the north-
western region of the country [23], with the species
Microfilaria tucumana first described [24] followed by
Microfilaria dermaquayi [13,25], a homonym ofMansonella
ozzardi [26], being described later. The high prevalence
in the Tucumán, Salta, and Jujuy provinces in north-
western Argentina were reported by Mühlens et al. [13].
Mansonella ozzardi is endemic to the subtropical
mountainous rainforest in the north-west region of
Argentina [27]. In this region, transmission is related to
ceratopogonid midges, Culicoides lahillei (main vector)
and Culicoides paraensis (secondary vector) and black
flies, Simulium exiguum (secondary vector) [28]. Although
M. ozzardi is considered a relatively non-pathogenic filar-
ial parasite, its pathogenicity is still a controversial subject
requiring further study [29,30]. There is currently a lack of
information about this disease, with the latest reports
being those of Krolewiecki et al. [31] and Veggiani et al.
(personal communication) on the influence of ivermectin
in patients and the epidemiology of the disease in
Argentina, respectively. A high prevalence of filariasis
(20.7%) was observed in one locality in the north-west
region of the country [27]. A similar result has been ob-
served (a prevalence of 26.0%) in a rural community in
the Bolivian Chaco region [32].
Plasmodium nematodes co-infection was widely reported
in America [33-37]. Aráoz and Biglieri [23] and Rosenbusch
[25] have cited numerous cases of people with microfilaria
co-infection in the north-west region of Argentina. Later,
Mühlens et al. [13] reported the finding of this microfil-
aria in blood smears with malaria parasites in the same
region. Since this last paper, there were no reports of
co-infections of Plasmodium microfilaria in the country;
thus, the current study is the first report of the presence
of P. vivax and M. ozzardi after several decades.
According to the World Health Organization (WHO)
[19], Argentina is involved in the National Pre-Elimination
Programme of Malaria with the aim to focus on the active
detection of autochthonous cases. It has implemented
several studies where the existence of co-infection of
P. vivax with others parasites is considered important.
The present study aimed to detect co-infection with
P. vivax and M. ozzardi in patients with a diagnosis
of malaria who received anti-malaria treatment with




From October to December 2012, it was performed a
preliminary analysis of 166 thick and thin smears frompatient blood samples from different towns and cities
situated in north-western Argentina, at the border with
Bolivia, where there are still reports of imported malaria
cases. These towns and cities included Aguas Blancas
(22° 43′ S; 64° 22′ W), El Oculto (23° 06′ S; 64° 30′ W),
San Ramón de la Nueva Orán (23° 08′ S; 64° 20′ W),
Pichanal (23° 19′ S; 64° 13′ W), Embarcación (23° 13′ S;
64° 06′ W) General Ballivian (22° 56′ S; 63° 52′ W),
General Mosconi (22° 36′ S; 63° 49′ W) Tartagal (22°
32′ S; 63° 49′ W), Aguaray (22° 16′ S; 63° 44′ W),
Campo Durán (22° 14′ S; 63° 42′ W) and Salvador
Mazza (22° 04′ S; 63° 43′ W) (Figure 1).
The reported case corresponds to a 70-year-old male
living in the Tartagal locality, which belongs to the
General José de San Martín Department, Salta prov-
ince, north-west Argentina. The patient came to the
regional malaria base with fever and chills. Microscopic
revision was conducted on thick and thin smears, and par-
asites were visualized by using a binocular microscope
with immersion lenses at 100% magnification. These tests
revealed the presence of P. vivax - M. ozzardi parasites
(Figure 2). The diagnosis was confirmed by a qualified
specialist laboratory technician from the Reference
Malaria Base of Salta City, Ministry of Health of Argentina.
The presence of P. vivax trophozoites was observed in
the blood sample, showing an amoeboid cytoplasm and
large chromatin dots. Mansonella ozzardi microfilaria
appeared as described by Adami et al. [30] at the anter-
ior region of the cephalic space that ends where the
nuclear column begins, with an initial detailed nucleus
followed by two that appear attached. The total length of
the microfilaria was 148.2 μm and their diameter was
3.1 μm; these values were included in the averages
established for this species.
An epidemiological sheet was completed with the
microscopic analysis of blood samples, including infor-
mation related to the consultation date (day, month,
year), the patient’s name and address, place where the
disease was supposedly acquired, travel during the previ-
ous three months, type of work, nationality and case
classification. The epidemiological investigation revealed
that the man living in Tartagal City and working in a ba-
nana farm close to the city acquired the malarial disease
in Yacuiba (city on the Bolivia border) where he travelled
two weeks before the report. The patient did not suffer
any type of pain, with the presence of disease revealed
by intermediate fever episodes. After laboratory confirm-
ation, the treatment of the patient proceeded with a
combination of chloroquine/primaquine pills for two
consecutive weeks. The doses used were consistent with
WHO guidelines [17] as follows: one tablet per day of
chloroquine phosphate BP 242 mg (Micro Labs Limited,
Hosur, India) for two weeks and one tablet per day of
Aralen phosphate/primaquine phosphate 15 mg (Sanofi
Figure 1 Geographical distribution of the localities in north-western Argentina (Aguas Blancas = 1, El Oculto = 2, San Ramón de la Nueva
Orán = 3, Pichanal = 4, Embarcación = 5, General Ballivian = 7, General Mosconi = 8, Tartagal = 9, Aguaray = 10, Campo Durán = 11
and Salvador Mazza = 12).
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three consecutive days at the start of treatment. At this
time, treatment for the filariasis parasite was not consid-
ered, and no complications were reported during or after
the malaria treatment.Figure 2 Microscopic analysis of Giemsa-stained thin blood-smears fr
ozzardi microfilaria parasites (A = neutrophils, B = lymphocyte and CConsent
The study methodology, including the ethical aspects,
was approved by the Ministry of Health of Argentina,
which has an Ethical Committee who revised these as-
pects. They are included in the Protocol of the Manualom a patient infected with Plasmodium vivax and Mansonella
= trophozoites).
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Discussion
In north-western Argentina, the diagnosis of malaria is
directly related to intermediate fever episodes, but the
diagnosis of filariasis is a consequence of blood smear
analysis for malaria. The first reports of malaria in
Argentina showed that the disease was the most import-
ant parasitic disease of the time, not only because of the
number of cases reported but also because of their wide
geographical distribution across the country. The major-
ity of malaria reports cited P. vivax as the most abun-
dant parasite that appeared in blood smears, as well as
the high prevalence of co-infection with M. ozzardi [26].
After the malaria eradication programme in 1959, mal-
aria cases decreased considerably before a resurgence in
disease in 1967 [38]. Since 1967, the active search for
malaria patients by technicians of the Ministry of Health
of Argentina, with adequate primaquine/chloroquine
treatment, and the spraying in dwellings of the mosquito
vector with 2.5% deltamethrin has reduced the incidence
of malaria cases. The latest research indicates that
the few autochthonous malaria cases were positive
for P. vivax. This species seems to be the only para-
site incriminated in malaria in human beings, and the
most tolerant to the climatic and environmental changes,
enabling its survival during this time in north-western
Argentina [17-19,39]. The number of malaria cases with
M. ozzardi co-infection also decreased dramatically during
the last few decades, with the latest studies reporting
high prevalence of microfilaria only within isolated
communities, but affecting both sexes and with increasing
infection rates progressively with increasing patient age
[27,40-42].
Conclusion
From the present report, it has concluded that further
studies are necessary to search for cases of co-infection
with P. vivax and M. ozzardi. These studies should try
to establish the prevalence of co-infection and quantify
the potential effects of malaria treatment on the devel-
opment of M. ozzardi and the impact of this microfilaria
on the immunity of humans infected with P. vivax in
north-western Argentina. The results presented in this
study could be used as the basis for future studies
involving the interaction of these parasites and include
other localities on the Bolivian border, considering that
the parasites and their vectors do not recognize geo-
graphical barriers to their transmission.Competing interests
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